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Abstract
Background: Little is known about pharmacy owners’ commitment to public health and health policy goals in the
strategic planning of their business. The aim of this study was to explore factors associated with health service
orientation and active product marketing orientation of Finnish community pharmacy owners.
Methods: A national cross-sectional e-mail survey was sent to private community pharmacy owners in Finland (n =
581) in 2013. Based on the structured, Likert-type survey instrument, two sum scales measuring strategic orientation
towards health service provision (13 items, score range 0–26) and active product marketing (8 items, score range 0–
16) were developed (Cronbach’s Alpha 0.836 and 0.699, respectively). Characteristics of the pharmacy owners and
their pharmacy business as well as actual service provision were used as background variables.
Results: Concerning health service orientation, 50% of the respondents received at least 20 points out of the
maximum 26 points (score range: 0–26). For active product marketing orientation, 75% of the pharmacy owners
had at least 14 points and 44% received full 16 points (score range: 0–16). The score distribution was skewed
towards strong health service orientation, but the actual service score was heavily skewed towards few services or
no services. Two-thirds of the pharmacy owners reported having available 2 or less services. The health service
orientation was not influenced by any of the background variables used, but three of them influenced active
product marketing orientation, namely business location, annual prescription volume and belonging to a marketing
chain of individual community pharmacies.
Conclusion: Large pharmacies located close to rivals and belonging to marketing chains of individual community
pharmacies differentiated as those having a high product marketing orientation. The health service orientation was
not influenced by any of the explanatory variables used in this study. The discrepancy between high health service
orientation scores and low actual service provision scores needs further investigation. The contradiction that exists
between pharmaceutical policy goals and the generation of income of pharmacies should also be examined as a
contributing factor in this respect.
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Background
The marketplace of community pharmacies is undergoing
remarkable changes in many countries throughout the
world [1–4]. This can be due to major societal, financial
and political changes which can lead to major changes in
social and health services systems. A dominating political
trend has been towards deregulation of pharmacy owner-
ship and non-prescription medicine sales [4]. The main ar-
guments favoring deregulation have been related to better
access to pharmacies and pharmaceuticals in terms of num-
ber of outlets, opening hours, location and prices of medi-
cines [5, 6]. On the other hand, there has been a demand
for pharmacies to extend their services towards health care
to support rational and safe use of medicines. This trend to-
wards health services has been strongly supported by the
pharmacy profession (e.g., FIP/WHO 2011), though it has
been challenging to communicate it to policy makers and
consumers, despite the fact that consumers trust pharma-
cists and are satisfied with their customer service [3, 7, 8].
However, consumers are not aware of the health service’s
pharmacists offer but regard them as traditional medicine
distributors and dispensers [1, 2, 9, 10].
Community pharmacy owners as private entrepreneurs
decide on the strategic development of their business.
However, it is not well known how committed the phar-
macy owners are to public health and health policy goals
in the strategic planning of their business [10]. There ex-
ists previous research on how the earnings model of
pharmacies has been reformed in some countries [11,
12]. The aim has been to move to a service-based earn-
ings model that would encourage pharmacists to provide
services to health care to support rational and safe use
of medicines [11, 12].
The community pharmacy system in Finland consists
of approximately 800 privately owned outlets, of which
about 600 are main pharmacies and 200 subsidiary out-
lets [13]. In addition to these, there are two university-
owned community pharmacies with 18 outlets in differ-
ent parts of Finland. The number of outlets has
remained quite the same throughout the years. Owner-
ship of a pharmacy is granted via a license from the Na-
tional Agency for Medicines. Pharmacy chains are not
allowed, but pharmacy owners can operate up to three
subsidiaries, smaller service points with a limited assort-
ment and online pharmacies that can sell prescription
and non-prescription medicines. Pharmacy owners have
established marketing chains to gain purchasing power
and marketing volume, as well as jointly organize
personnel training. A majority (80%) of the pharmacies´
market share consists of prescription drug sales, while
the rest consists of non-prescription drug sales (14%)
and sales of other health-related products (6%) [13].
Finnish community pharmacies pay an additional gov-
ernment fee, a “pharmacy tax”, which is progressively
calculated as a proportion of annual turnover (range 1–
11%, mean 7%) [13]. The purpose of the pharmacy tax is
to offset the profits of pharmacies, but the tax does not
compensate the large income gap between the pharma-
cies with low and high turnover.
The structure of the Finnish community pharmacy sys-
tem has remained quite the same throughout the last de-
cades, compared to the structural changes towards
liberalization within other Nordic and European Union
countries [4, 6]. Previous and current medicines policy
documents have strategically integrated community phar-
macies into the social and healthcare system [14–17]. The
same tendency can be seen in the most recent policy doc-
uments outlining community pharmacies’ tasks and func-
tions in the major healthcare reform currently under way
in Finland [15].
We conducted a national survey in Finland, in 2013,
involving all private community pharmacy owners in
order to assess whether having a strategy influenced
their health service and active product marketing orien-
tation [18]. It was found that not all pharmacy owners
had a strategy, but their strategic vision by 2020 con-
cerning health services orientation was the same regard-
less of whether they had a strategy or not. Having a
strategy was associated with variables indicating active
product marketing orientation, such as whether the
pharmacy had a person responsible for marketing
campaigns and actively invested in add-on-sales of non-
prescription medicines and non-medical products. Phar-
macy owners running their outlets in competitive
marketplaces, such as in a city or commercial center,
were most likely to have a strategy. This present study
continued investigating the same theme concerning pri-
vate pharmacy owners’ strategic orientation towards
health services and active product marketing. The spe-
cific aim of this study was to explore factors associated
with health service orientation and active product mar-
keting orientation of Finnish community pharmacy
owners.
Methods
Study design
This study was conducted by using data derived from a
larger national cross-sectional e-mail survey sent to pri-
vate community pharmacy owners in Finland, investigat-
ing their strategy work related to running their
community pharmacy business [18]. The survey covered
all members of the Association of Finnish Pharmacies (n
= 581 at the time the survey was conducted in March
2013), forming a majority of the approximately 600 pri-
vate community pharmacy owners in Finland. The de-
tails regarding conducting the survey as well as the
development of the survey instrument have been re-
ported elsewhere [18].
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Measures used in this study and statistical analysis
The entire survey instrument is presented in Additional
File 1. The survey instrument primarily consisted of
structured questions applying a 5-point Likert-scale for-
mat, with the options ranging from fully agree to fully
disagree. The questions were divided into five sections:
characteristics of the pharmacy owner, characteristics of
the pharmacy’s strategic development, marketing efforts,
and range of services provided in the pharmacy at the
time of the survey and plans on investing in health care-
oriented service development by 2020.
In our previous study, the data were divided into di-
chotomies based on whether the pharmacy had a strat-
egy or not [18]. Thus, having a strategy was the
dependent variable. Among the explanatory variables
were two sum scales that were constructed to describe
health services orientation and active product marketing
orientation [18]. These sum scales were used as
dependent dichotomous variables (strong or weak orien-
tation) in the present study. The explanatory variables
included characteristics of the pharmacy owner, such as
work experience as a pharmacy owner and gender; char-
acteristics of the pharmacy business, such as pharmacy’s
location by province and location area (e.g., countryside,
city center), annual prescription volume and turnover.
Other explanatory variables used were: 1) whether the
pharmacy owner had a strategy for running his/her
pharmacy business; 2) whether he/she had plans to re-
sign/retire, or to apply for a license for another phar-
macy within 3 years (if the new license is granted by the
Medicines Agency, the owner needs to terminate their
existing license); 3) whether the pharmacy belonged to a
marketing chain of individual community pharmacies;
and 4) the range of actual services available in their
pharmacy at the time of the study in 2013, presented as
a summative variable.
The summative variable measuring health service
orientation was developed by combining 13 independent
Likert-scale variables related to health service orientation
of Finnish community pharmacies at the time of the sur-
vey (Additional File 2, Appendix 1). The same kind of
summative variable was calculated for eight independent
variables related to active product marketing to
operationalize active product marketing orientation
(Additional File 2, Appendix 1). The internal consistency
of both summative variables was calculated by using reli-
ability analysis (Cronbach’s Alpha).
Responses were scored so that the fully agree and
agree to some extent responses yielded 2 points while
other responses yielded 0 points. The score range for 13
variables measuring health service orientation was 0–26,
and for 8 variables measuring active product marketing
orientation was 0–16. Responses to both summative var-
iables were divided into two dichotomous categories to
indicate 1) strong or weak health services orientation
(strong orientation: scores 20–26; weak orientation:
scores 0–18) and 2) strong or weak active product mar-
keting orientation (strong orientation: scores 14–16;
weak orientation: scores 0–12). The division into strong
and weak orientation was made by halving the frequen-
cies. A bivariate analysis was performed to explore the
association between background variables, i.e., explana-
tory variables, health service orientation and active prod-
uct marketing orientation. Values of p < 0.05 were
considered statistically significant.
The pharmacy owners were also asked to report the
range of actual services available in their pharmacy at
the time of the study in 2013. For the analysis, a summa-
tive variable was calculated based on the services avail-
able: each service equaled one point. Thus, the scale
range was 0–10. The correlations of the summative vari-
able reflecting actual service provision with active prod-
uct marketing orientation and with health services
orientation was calculated. Appendix 2 provides a more
detailed description of the health-related services in-
cluded in this study that were available in Finnish com-
munity pharmacies or part of the pharmacies at the time
of the survey in 2013.
Responses were analyzed using the SPSS program (ver-
sion 22.0). The results are presented as frequency distri-
butions and cross tabulations. The statistical significance
was tested using the Chi Square test (p-value of < 0.05
was considered statistically significant). The correlations
between the variables were calculated by Pearsons’s cor-
relation test.
Results
The response rate was 34% (n = 198). Of the respon-
dents, 42% were experienced pharmacy owners who had
owned a pharmacy for more than 10 years. The majority
(72%) of the respondents were women. The gender dis-
tribution and their pharmacy prescription volumes rep-
resented pharmacies in Finland well. The respondents
represented evenly pharmacies of different sizes in terms
of annual turnover and prescription volume. Of the re-
spondents 45% operated their pharmacy in a rural com-
munity, and 41% in a location with rivals (22% in city
centers and 19% in city commercial centers such as
shopping malls). About one-third (38%) of the pharma-
cies belonged to a marketing chain. Almost two-thirds
(63%) reported that their pharmacy had a strategy. Of
the respondents, 40% planned to retire or apply for a li-
cense for a new pharmacy from the Finnish Medicines
Agency within a 3-year period after the time of the sur-
vey. More detailed background information has been re-
ported elsewhere [18].
Automated dose dispensing was the most common
health-oriented service provided by most of the
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responding pharmacies (77%) (Fig. 1). Other health-
oriented services were provided by less than half of the
pharmacies: health measuring was the most provided
(35%) while health check service was the least provided
(8%).
The internal consistency for the set of 8 variables indi-
cating a pharmacy’s active product marketing orientation
was 0.699 (Cronbach’s Alpha), and for the 13 variables
indicating pharmacy’s health service orientation it was
0.836. Concerning active product marketing orientation,
44% of the pharmacies received a full 16 points and 75%
at least 14 points (Fig. 2). The score range was more
scattered for health services orientation, although 50% of
the respondents received at least 20 points out of the
maximum 26 points (Fig. 3). The summative score pres-
entation of the health-oriented services provided at the
time of the survey in 2013 was controversial, as 66% of
the pharmacy owners reported having two or less ser-
vices out of the ten listed in the survey instrument avail-
able (Fig. 4).
None of the background variables influenced the
health service orientation score (Chi Square test), while
three out of eight variables were found to have statisti-
cally significant association with active product market-
ing orientation (Table 1). These variables were pharmacy
location (p = 0.041), prescription volume (p = 0.047) and
operating as a part of a pharmacy chain (p < 0.001). No
correlation was found between actual service provision
and health service orientation (Pearson correlation
0.098). There was positive correlation between actual
service provision and active product marketing orienta-
tion (Pearson correlation 0.503).
Discussion
Despite the international and national discussion over
the roles and activities of community pharmacies, their
societal status remains undefined between commercial
and public health functions. Our study is among few
published studies that have examined this issue from the
perspective of individual pharmacy owners who bear fi-
nancial responsibility for their business. Research and in-
ventories have begun to emerge on the remuneration
and effectiveness, even cost-effectiveness, of pharmacy
services, but a large-scale breakthrough in healthcare-
oriented pharmacy services is still missing [19–21].
Our results indicate that the health service orientation
of Finnish community pharmacies was not influenced by
any of the background variables used in this study, cov-
ering a wide range of factors crucial for determining
pharmacy business in Finland. On the other hand, three
of the factors influenced active product marketing orien-
tation, namely business location, annual prescription vol-
ume and belonging to a marketing chain of individual
community pharmacies. The results also showed a dis-
crepancy between health service orientation and the ser-
vices provided: the score distribution was skewed
towards strong health service orientation, but the actual
service score was heavily skewed towards few services or
no services. Two-thirds of the responding pharmacy
owners reported having two or less services out of the
ten listed in the survey instrument available. The actual
situation may have been even less favorable for health
service provision because only about one-third of all
community pharmacy owners responded to our survey.
Among non-respondents may have been many pharmacy
Fig. 1 Provision of different health-oriented services in community pharmacies at the time of the survey in 2013 (% of the responding pharmacy
owners, n = 188–196; the number of actual respondents is marked for each service; respondents could identify as many services as applicable,
see Additional file 2: Appendix 2 for more detailed description of the health-related services included in the study)
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owners less interested in professional service develop-
ment and less committed to medicines policy goals fa-
voring integration of community pharmacies in
healthcare. This assumption is confirmed by evidence
from other studies on community pharmacy services:
they are consistent with the finding that a minority of
community pharmacists actively provide healthcare-
oriented services other than medication counseling [12].
Pharmacies located in shopping centers were most ac-
tive in product marketing, while pharmacies located in
rural communities and city centers were the least active.
This may be explained by the fact that pharmacies in
rural communities do not have local competitors, so
they do not need to compete for customers and market
share in the same way as urban pharmacies. We also
found that active marketing was not as common in small
pharmacies than it was in middle-sized and large phar-
macies, as measured by turnover and prescription vol-
ume. All these results were relatively expected, as was
the finding that belonging to a marketing chain of indi-
vidual community pharmacies was associated to a more
active product marketing. A part of Finnish community
pharmacies belong to a marketing chain. The marketing
chain, at its best, could facilitate investment in and im-
plementation of health-oriented services as individual
pharmacies may not have enough resources to produce
Fig. 2 Pharmacies’ active product marketing orientation as measured by a sum scale consisting of 8 variables (% of the responding pharmacy
owners, n = 198; the range of the sum scale 0–16, see Additional file 2: Appendix 1 for more detailed description of the sum scale)
Fig. 3 Pharmacies’ health services orientation as measured by a sum scale consisting of 13 variables (% of the responding pharmacy owners, n =
198; the range of the sum scale 0–26, see Additional file 2: Appendix 1 for more detailed description of the sum scale)
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and market the services alone [22]. However, traditional
chain pharmacies have been strongly oriented to active
product marketing which can be seen in many countries
where these chains exist [10, 11]. Even in high income
countries with a high number of residents without af-
fordable health insurance and health care coverage, such
as the United States, they have not acquired a role of
health services providers [2]. Likewise, in Finland phar-
macy chains have drifted pharmacies away from their
primary health care scope towards more commercially-
oriented enterprises selling health and wellness products
and cosmetics, which are more profitable than selling
heavily regulated medicinal products.
Even though not investigated in our study, policy-
making can perform as a factor contributing to the di-
lemma that we found concerning pharmacy owners’
strategic commitment to health service orientation,
while actual business is being driven by active product
Fig. 4 The summative presentation of health-oriented services actually provided at the time of the survey in 2013 (each available service yielded
1 point, score range 0–10, see Additional file 2: Appendix 2 for more detailed description of the health-related services included in the study)
Table 1 Association between pharmacy location area, annual prescription volume, belonging to a marketing chain of individual
private pharmacies and active product marketing orientation (sum scale)
Active product marketing orientation (sum scale) Low
(score 0–12)
High
(score 14–16)
Total P-value
% n % n n
Business location area p = 0.041
Countryside 62 55 38 34 89
City, center 64 27 36 15 42
City, suburb 52 14 48 13 27
City, commercial center (e.g., shopping mall) 37 14 63 24 38
Total 56 110 44 86 196
Annual prescription volume p = 0.047
Less than 40,000 71 37 29 15 52
40,000–600,000 43 16 57 21 37
60,001–100,000 55 35 45 29 64
More than 100,000 50 22 50 22 44
Total 56 110 44 87 197
Whether the pharmacy belongs to a marketing chain of individual private pharmacies p < 0.001
No 72 59 28 23 82
Yes 43 48 57 63 111
Total 55 107 45 86 193
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marketing [18]. This is because national incentives for
long-term development of health-oriented services has
been lacking, leading to more commercial strategic deci-
sions at the individual pharmacy level in order to assure
profits. Legislation and governmental policy papers may
define health-oriented tasks for community pharmacies,
but pharmacies’ financial ability to support this shift,
which requires long-term development, has not been in-
cluded in these policies, and has hardly been officially
discussed [14, 23]. More should be learnt from countries
that have succeeded to integrate community pharmacy
services in their public health policies and strategies,
such as the National Health Service (NHS) of the United
Kingdom [2]. Further, more research should be available
in order to acquire better understanding of the mecha-
nisms leading to enhanced coordination and community
pharmacists’ involvement in patient care and effective-
ness as well as the economic impact of their involvement
in care outcomes, to support large-scale implementation
of these services [24–26].
Implementation of novel health-oriented services is a
long process that requires strategic commitment and re-
source allocation [27]. Examples from other countries
indicate that pharmacies can strengthen their profes-
sional and societal role by specializing in health services
supporting safe and rational medication use [28]. It is
still possible for independent, smaller community phar-
macies to compete successfully following a differenti-
ation or focused differentiation strategy which is well
executed [3]. Finnish community pharmacies have par-
ticularly invested in improving medication counseling
services since the 1990s, and more recently improved
community pharmacists’ involvement in collaborative
medication reviews [8, 24, 29]. The commitment of indi-
vidual pharmacy owners to shared national health and
medicines policy goals has been important. Finnish phar-
macies’ polarization to two categories is evident: those
basing their business on traditional dispensing and active
product sales, and those willing to extend their opera-
tions towards professional health-oriented services. The
situation is also similar in other countries [19].
The major limitation of this national study is the low
response rate (34%), thus the results can only be consid-
ered as indicative. The response rate is similar to other
recent email surveys targeting community pharmacists
and pharmacy owners in Finland [30]. The geographic
location, gender distribution and prescription volume of
the respondents’ pharmacies represented all pharmacies
in Finland well. It is possible that pharmacy owners who
are interested in health service orientation and product
marketing strategy work have been more active in
responding than others [13]. Another limitation may be
that the data is 7 years old and perhaps the practice has
changed since data collection. The ongoing social and
health services reform in Finland has shifted the political
focus towards health service orientation after the survey
data was acquired [23]. There would be a need for fur-
ther research on the discrepancy between strategic
health service orientation and actual service provision
when discussing the future of pharmacies. More research
is needed to understand root causes that hinder the
larger-scale implementation of healthcare-oriented ser-
vices in routine community pharmacy practice while
strengthening the focus on active product sales. The
contradiction that exists between pharmaceutical policy
goals and the generation of income of pharmacies by
providing health-oriented services should be examined
as a contributing factor in future studies.
Conclusions
Large pharmacies located close to rivals and belonging
to marketing chains of individual community pharma-
cies differentiated as those having a high product mar-
keting orientation. The health service orientation was
not influenced by any of the explanatory variables used
in this study. The discrepancy between high health ser-
vice orientation scores and low actual service provision
scores needs further investigation. The contradiction
that exists between pharmaceutical policy goals and the
generation of income of pharmacies should be examined
as a contributing factor in this respect.
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